Potential Universal Cancer Vaccine Will Start Clinical Trials In Ovarian Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
Immunovaccine obtains approval from FDA to conduct a small Phase I trial followed immediately by a larger Phase II for DPX-Survivac in ovarian cancer.